Summary of Purpose
This study will test the safety and effectiveness of a protein called E-selectin, given as a nasal spray, in preventing the formation of blood clots that can cause stroke. In animal studies, animals that received E-selectin in the nose on a regular schedule had almost no strokes compared with those that did not receive it. Patients over age 45 who have had a stroke or transient ischemic attack (TIA) within 1 to...Read More →
The following dates are available for this trial. Trial information last updated on 3 May 2010.
|1 Mar 2001||9 Mar 2001||Unavailable||1 Feb 2004||1 May 2010||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
Patient Recruitment and Public Liaison Office Building 61 10 Cloister Court Bethesda, Maryland email@example.com